BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 23 March 2007. doi:10.1136/bjo.2007.115386
British Journal of Ophthalmology 2007;91:1122-1124
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjo.2007.115386v1
91/9/1122    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maia, M.
Right arrow Articles by Belfort, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maia, M.
Right arrow Articles by Belfort, R., Jr
Topic Collections
Right arrowRelevant Articles

SCIENTIFIC REPORT

Effects of intravitreal triamcinolone acetonide injection with and without preservative

Mauricio Maia, Michel Eid Farah, Rubens N Belfort, Fernando Marcondes Penha, Acácio A S Lima Filho, Fabio Bom Aggio, Rubens Belfort Jr

Federal University of São Paulo, Department of Ophthalmology, Vision Institute, São Paulo, Brazil

Correspondence to:
Mauricio Maia, MD, Vision Institute, Rua Botucatu 822, São Paulo - SP 04023-062, Brazil; maiaretina{at}uol.com.br


ABSTRACT
Aims: To evaluate the effects of intravitreal injection of preservative-free triamcinolone acetonide (PFTA) and TA containing preservative (KE).

Methods: A retrospective review was conducted of 646 intravitreal 4 mg/0.1 ml steroid injections in 471 eyes. A total of 577 intravitreal injections of PFTA and 69 injections of KE were administered in non-randomised eyes. No supernatant removal from KE was performed. Non-infectious endophthalmitis was defined as pseudohypopyon/hypopyon with or without an inflammatory reaction that regressed after steroid eye drop instillation. Ocular hypertension was defined as more than 23 mm Hg with Goldman applanation tonometry. Patients were followed and examined 1, 7 and 28 days, and 3, 4, 6 and 12 months after injection and annually thereafter. Statistical analysis was performed using Fisher’s exact test and X2 test. p Values <0.05 were considered significant.

Results: Both groups did not differ in demographics (p>0.05). Follow-up ranged from 6 to 57 months (mean 13, SD 7.5). Ocular hypertension was present in 127 eyes (20%), but both groups did not differ significantly (p = 0.167). Four eyes (3.15%) required trabeculectomy. Non-infectious endophthalmitis developed in 12 eyes (1.9%) and varied significantly in both groups (p = 0.005). One eye developed bacterial endophthalmitis (0.15%).

Conclusions: Non-infectious endophthalmitis was observed significantly more often after KE injections (7.3%) than after PFTA injections (1.2%) (p<0.05). An inflammatory reaction was more clinically relevant in the KE group than in the PFTA group.


Abbreviations: IOP, intraocular pressure; KE, triamcinolone acetonide containing preservative; PFTA, preservative-free triamcinolone acetonide; TA, triamcinolone acetonide


Relevant Articles

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2007 91: 1099. [Extract] [Full Text] [PDF]

Effects of triamcinolone acetonide injections with and without preservative
Jost B Jonas
Br. J. Ophthalmol. 2007 91: 1099-1101. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.